Background: In 1997 the US Environmental Protection Agency (EPA) established the National Ambient Air Quality Standard (NAAQS) for fine particulate matter (PM 2.5 ), largely because of its positive relationship to total mortality in the 1982 American Cancer Society Cancer Prevention Study (CPS II) cohort. Subsequently, EPA has used this relationship as the primary justification for many costly regulations, most recently the Clean Power Plan. An independent analysis of the CPS II data was conducted in order to test the validity of this relationship.
Introduction
In 1997 the US Environmental Protection Agency (EPA) established the National Ambient Air Quality Standard (NAAQS) for fine particulate matter (PM 2.5 ), largely because of its positive relationship to total mortality in the 1982 American Cancer Society (ACS) Cancer Prevention Study (CPS II) cohort, as published in 1995 by Pope et al. 1 The EPA uses this positive relationship to claim that PM 2.5 causes premature deaths. However, the validity of this finding was immediately challenged with detailed and well-reasoned criticism. [2] [3] [4] The relationship still remains contested and much of the original criticism has never been properly addressed, particularly the need for truly independent analysis of the CPS II data.
The EPA claim that PM 2.5 causes premature deaths is implausible because no etiologic mechanism has ever been established and because it involves the lifetime inhalation of only about 5 g of particles that are less than 2.5 mm in diameter. 5 The PM 2.5 mortality relationship has been further challenged because the small increased risk could be due to wellknown epidemiological biases, such as, the ecological fallacy, inaccurate exposure measurements, and confounding variables like copollutants. In addition, there is extensive evidence of spatial and temporal variation in PM 2.5 mortality risk (MR) that does not support 1 national standard for PM 2.5 .
In spite of these serious problems, EPA and the major PM 2.5 investigators continue to assert that their positive findings are sufficient proof that PM 2.5 causes premature deaths. Their premature death claim has been used to justify many costly EPA regulations, most recently, the Clean Power Plan. 6 Indeed, 85% of the total estimated benefits of all EPA regulations have been attributed to reductions in PM 2.5 -related premature deaths. With the assumed benefits of PM 2.5 reductions playing such a major role in EPA regulatory policy, it is essential that the relationship of PM 2.5 to mortality be independently verified with transparent data and reproducible findings.
In 1998, the Health Effects Institute (HEI) in Boston was commissioned to conduct a detailed reanalysis of the original Pope 1995 findings. The July 2000 HEI Reanalysis Report (HEI 2000) included "PART I: REPLICATION AND VALIDATION" and "PART II: SENSITIVITY ANALYSES." 7 The HEI Reanalysis Team lead by Daniel Krewski successfully replicated and validated the 1995 CPS II findings, but they did not analyze the CPS II data in ways that would determine whether the original results remained robust using different sources of air pollution data. For instance, none of their models used the best available PM 2.5 measurements as of 1995.
Particularly troubling is the fact that EPA and the major PM 2.5 investigators have ignored multiple null findings on the relationship between PM 2.5 and mortality in California. These null findings include my 2005 paper, 8 2006 clarification, 9 2012 American Statistical Society Joint Statistical Meeting Proceedings paper, 10 and 2015 International Conference on Climate Change presentation about the Clean Power Plan and PM 2.5 -related cobenefits. 6 There is now overwhelming evidence of a null PM 2.5 mortality relationship in California dating back to 2000. The problems with the PM 2.5 mortality relationship have generated substantial scientific and political concern.
During 2011 to 2013, the US House Science, Space, and Technology Committee (HSSTC) repeatedly requested that EPA provide access to the underlying CPS II data, particularly since substantial Federal funding has been used for CPS II PM 2.5 mortality research and publications. On July 22, 2013, the HSSTC made a particularly detailed request to EPA that included 49 pages of letters dating back to September 22, 2011. 11 When EPA failed to provide the requested data, the HSSTC issued an August 1, 2013 subpoena to EPA for the CPS II data. 12 The ACS refused to comply with the HSSTC subpoena, as explained in an August 19, 2013 letter to EPA by Chief Medical Officer Otis W. Brawley. 13 Then, following the subpoena, ACS has refused to work with me and 3 other highly qualified investigators regarding collaborative analysis of the CPS II data.
14 Finally, HEI has refused to conduct my proposed CPS II analyses. 15 However, my recent acquisition of an original version of the CPS II data has made possible this first truly independent analysis.
Methods
Computer files containing the original 1982 ACS CPS II deidentified questionnaire data and 6-year follow-up data on deaths from September 1, 1982 through August 31, 1988, along with detailed documentation, were obtained from a source with appropriate access to these data, as explained in the "Acknowledgments." This article presents my initial analysis of the CPS II cohort and it is subject to the limitations of data and documentation that is not as complete and current as the data and documentation possessed by ACS.
The research described below is exempt from human participants or ethics approval because it involved only statistical analysis of existing deidentified data. Human participants' approval was obtained by ACS in 1982 when each individual enrolled in CPS II. Because of the epidemiologic importance of this analysis, an effort will be made to post on my Scientific Integrity Institute website a version of the CPS II data that fully preserves the confidentiality of all of participants and that contains enough information to verify my findings.
Of the 1.2 million total CPS II participants, analysis has been done on 297 592 participants residing in 85 counties in the continental United States with 1979 to 1983 EPA Inhalable Particulate Network (IPN) PM 2.5 measurements. 16, 17 Among these participants, there were 18 612 total deaths from September 1, 1982 through August 31, 1988; 17 329 of these deaths (93.1%) had a known date of death. Of the 297 592 participants, 292 277 had age at entry of 30 to 99 years and sex of male [1] or female [2] . Of the 292 277 participants, 269 766 had race of white [1, 2, 5] or black [3, 4] ; education level of no or some high school [1, 2] , high school graduate [3] , some college [4, 5] , college graduate [6] , or graduate school [7] 7 The MA, which was equivalent to the US Census Bureau Standard Metropolitan Statistical Area (SMSA), always included the county containing the city with the HEI PM 2.5 data and often included 1 or more additional counties.
The SAS 9.4 procedure PHREG was used to conduct Cox proportional hazards regression. 18 Relative risks (RRs) for death from all causes and 95% confidence intervals (CI) were calculated using age-sex adjustment and full adjustment (age, sex, race, education, and smoking status, as defined above). Each of the 5 adjustment variables had a strong relationship to total mortality. Race, education, and smoking status were the 3 adjustment variables that had the greatest impact on the agesex-adjusted RR. The Pope 1995 and HEI 2000 analyses used 4 additional adjustment variables that had a lesser impact on the age-sex-adjusted RR.
In addition, county-level ecological analyses were done by comparing IPN PM 2.5 and HEI PM 2.5 values to 1980 ageadjusted white total death rates (DRs) determined by the Centers for Disease Control and Prevention (CDC) WONDER 19 and mortality risks (MRs) as shown in Figures 5 and 21 of HEI 2000. 7 Death rates are age adjusted to the 2000 US Standard Population and are expressed as annual deaths per 100 000 persons. The SAS 9.4 procedure REGRESSION was used to conduct linear regression of PM 2.5 values with DRs and MRs.
Appendix Table A1 7 and this current analysis. There is excellent agreement on age, sex, race, education, and smoking status. However, the IPN PM 2.5 averages are generally about 20% higher than the HEI PM 2.5 medians, although the differences range from þ78% to À28%. Enstrom Table 2 shows that during 1982 to 1988, there was no significant relationship between IPN PM 2.5 and total mortality in the entire United States. The fully adjusted RR and 95% CI was 1.023 (0.997-1.049) for a 10 mg/m 3 increase in PM 2.5 in all 85 counties and 1.025 (0.990-1.061) in the 50 original counties. Indeed, the fully adjusted RR was not significant in any area of the United States, such as, the states west of the Mississippi River, the states east of the Mississippi River, the 5 Ohio Valley states (Indiana, Kentucky, Ohio, Pennsylvania, and West Virginia), and the states other than the Ohio Valley states. The age-sex-adjusted and fully adjusted RRs in the states other than the Ohio Valley states are all consistent with no relationship and most are very close to 1.00. The slightly positive age-sex-adjusted RRs for the entire United States and the Ohio Valley states became statistically consistent with no relationship after controlling for the 3 confounding variables of race, education, and smoking status.
However, the fully adjusted RR for the entire United States was 1.082 (1.039-1.128) when based on the HEI PM 2.5 values in 50 counties. This RR agrees quite well with the fully adjusted RR of 1.067 (1.037-1.099) for 1982 to 1989, which is shown in 20 Thus, the positive nationwide RRs in the CPS II cohort depend upon the use of HEI PM 2.5 values. The nationwide RRs are consistent with no effect when based on IPN PM 2.5 values. The findings in Table 2 clearly demonstrate the large influence of PM 2.5 values and geography on the RRs. 21 In this instance, the California RRs are clearly dependent upon the number of counties used. Table 4 shows that the ecological analysis based on linear regression is quite consistent with the proportional hazard regression results in Tables 2 and 3 22 These analyses did not use or cite the high quality and widely known EPA IPN PM 2.5 data in spite of the fact that these data have been available in 2 detailed EPA reports since 1986. 16, 17 Lipfert informed HEI about the IPN data in 1998: "During the early stages of the Reanalysis Project, I notified HEI and the reanalysis contractors of the availability of an updated version of the IPN data from EPA, which they apparently obtained. This version includes more locations and a slightly longer period of time. It does not appear that the newer IPN data are listed in Appendix G, and it is thus not possible to confirm if SMSA assignments were made properly." 23 Thus, the HEI Reanalysis Team failed to properly "evaluate the sensitivity of the original findings to the indicators of exposure to fine particle air pollution used by the Original Investigators" and failed to select "all participants who lived within each MA for which data on sulfate or fine particle pollution were available." Since 2002, HEI has repeatedly refused to provide the cityspecific PM 2.5 -related MR for the 50 cities included in HEI 2000 Figure 21. 15 I estimated these MRs in 2010 based on visual measurements of HEI 2000 Figure 5 , and my estimates are shown in Appendix Table A1 . 25 Figure 21 and its MRs represented early evidence that there was no PM 2.5 -related MR in California. Appendix Table B1 shows the now overwhelming 2000 to 2016 evidence from 6 different cohorts that there is no relationship between PM 2.5 and total mortality in California. Indeed, the weighted average RR of the latest results from the 6 California cohorts is RR ¼ 0.999 (0.988-1.010).
26
The authors of the CPS II PM 2.5 mortality publications, which began with Pope 1995, have faced original criticism, 2-4 my criticism, [6] [7] [8] [9] [10] 14, 15 and the criticism of the HSSTC and its subpoena.
11-13 Now, my null findings represent a direct challenge to the positive findings of Pope 1995. All of this criticism is relevant to the EPA claim that PM 2.5 has a causal relationship to total mortality. The authors of Pope 1995, HEI 2000, and HEI 2009 need to promptly address my findings, as well as the earlier criticism. Then, they need to cooperate with critics on transparent air pollution epidemiology analyses of the CPS II cohort data.
Also, major scientific journals like the New England Journal of Medicine (NEJM) and Science, which have consistently written about the positive relationship between PM 2.5 and total mortality, need to publish evidence of no relationship when strong null evidence is submitted to them. In 2015, Science immediately rejected without peer reviewing 3 versions of strong evidence that PM 2.5 does not cause premature deaths. 5 In 2016, Science immediately rejected without peer reviewing this article. Indeed, this article was rejected by NEJM, Science, and 5 other major journals, as described in a detailed compilation of relevant correspondence. 27 Most troubling is the rejection by the American Journal of Respiratory and Clinical Care Medicine, which has published Pope 1995 and several other PM 2.5 mortality articles based on the CPS II cohort data.
In summary, the null CPS II PM 2.5 mortality findings in this article directly challenge the original positive Pope 1995 findings, and they raise serious doubts about the CPS II epidemiologic evidence supporting the PM 2.5 NAAQS. These findings demonstrate the importance of independent and transparent analysis of underlying data. Finally, these findings provide strong justification for further independent analysis of CPS II cohort data. 
